Whittier Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $146K | Hold |
699
| – | – | ﹤0.01% | 684 |
|
|
2026
Q1 | $120K | Sell |
699
-67
| -9% | -$12.3K | ﹤0.01% | 675 |
|
|
2025
Q4 | $140K | Sell |
766
-410
| -35% | -$67K | ﹤0.01% | 673 |
|
|
2025
Q3 | $188K | Hold |
1,176
| – | – | ﹤0.01% | 598 |
|
|
2025
Q2 | $148K | Sell |
1,176
-12
| -1% | -$1.5K | ﹤0.01% | 717 |
|
|
2025
Q1 | $163K | Sell |
1,188
-68
| -5% | -$9.72K | ﹤0.01% | 690 |
|
|
2024
Q4 | $192K | Sell |
1,256
-112
| -8% | -$18.9K | ﹤0.01% | 668 |
|
|
2024
Q3 | $265K | Sell |
1,368
-215
| -14% | -$45K | ﹤0.01% | 624 |
|
|
2024
Q2 | $367K | Sell |
1,583
-2,304
| -59% | -$501K | 0.01% | 538 |
|
|
2024
Q1 | $838K | Sell |
3,887
-210
| -5% | -$49.2K | 0.01% | 390 |
|
|
2023
Q4 | $1.06M | Buy |
4,097
+136
| +3% | +$33.4K | 0.02% | 347 |
|
|
2023
Q3 | $1.02M | Sell |
3,961
-22
| -0.6% | -$5.88K | 0.02% | 345 |
|
|
2023
Q2 | $1.13M | Sell |
3,983
-43
| -1% | -$12.8K | 0.02% | 333 |
|
|
2023
Q1 | $1.12M | Hold |
4,026
| – | – | 0.02% | 335 |
|
|
2022
Q4 | $1.11M | Sell |
4,026
-38
| -0.9% | -$10.7K | 0.02% | 335 |
|
|
2022
Q3 | $1.08M | Sell |
4,064
-267
| -6% | -$56.7K | 0.02% | 323 |
|
|
2022
Q2 | $883K | Sell |
4,331
-774
| -15% | -$158K | 0.02% | 373 |
|
|
2022
Q1 | $1.07M | Buy |
5,105
+69
| +1% | +$15K | 0.02% | 366 |
|
|
2021
Q4 | $1.21M | Sell |
5,036
-243
| -5% | -$62.5K | 0.02% | 345 |
|
|
2021
Q3 | $1.49M | Hold |
5,279
| – | – | 0.03% | 308 |
|
|
2021
Q2 | $1.83M | Sell |
5,279
-943
| -15% | -$286K | 0.03% | 277 |
|
|
2021
Q1 | $1.74M | Buy |
6,222
+444
| +8% | +$120K | 0.03% | 282 |
|
|
2020
Q4 | $1.42M | Sell |
5,778
-797
| -12% | -$206K | 0.03% | 284 |
|
|
2020
Q3 | $1.86M | Sell |
6,575
-97
| -1% | -$27.1K | 0.04% | 250 |
|
|
2020
Q2 | $1.78M | Sell |
6,672
-468
| -7% | -$141K | 0.05% | 233 |
|
|
2020
Q1 | $2.26M | Sell |
7,140
-355
| -5% | -$108K | 0.07% | 200 |
|
|
2019
Q4 | $2.22M | Buy |
7,495
+691
| +10% | +$192K | 0.06% | 225 |
|
|
2019
Q3 | $1.58M | Sell |
6,804
-8,862
| -57% | -$2.06M | 0.05% | 255 |
|
|
2019
Q2 | $3.66M | Sell |
15,666
-827
| -5% | -$191K | 0.11% | 174 |
|
|
2019
Q1 | $3.9M | Buy |
16,493
+420
| +3% | +$132K | 0.12% | 165 |
|
|
2018
Q4 | $4.84M | Buy |
16,073
+260
| +2% | +$83K | 0.17% | 134 |
|
|
2018
Q3 | $5.59M | Buy |
15,813
+19
| +0.1% | +$6.54K | 0.17% | 136 |
|
|
2018
Q2 | $4.58M | Sell |
15,794
-109
| -0.7% | -$30.6K | 0.15% | 144 |
|
|
2018
Q1 | $4.36M | Sell |
15,903
-4,407
| -22% | -$1.37M | 0.15% | 151 |
|
|
2017
Q4 | $6.47M | Buy |
20,310
+372
| +2% | +$119K | 0.23% | 120 |
|
|
2017
Q3 | $6.24M | Buy |
19,938
+746
| +4% | +$221K | 0.23% | 119 |
|
|
2017
Q2 | $5.21M | Buy |
19,192
+1,201
| +7% | +$318K | 0.2% | 124 |
|
|
2017
Q1 | $4.92M | Buy |
17,991
+761
| +4% | +$215K | 0.2% | 127 |
|
|
2016
Q4 | $4.89M | Sell |
17,230
-23,004
| -57% | -$6.82M | 0.21% | 123 |
|
|
2016
Q3 | $12.6M | Sell |
40,234
-193
| -0.5% | -$57.2K | 0.55% | 52 |
|
|
2016
Q2 | $9.78M | Buy |
40,427
+443
| +1% | +$117K | 0.43% | 64 |
|
|
2016
Q1 | $10.4M | Buy |
39,984
+690
| +2% | +$182K | 0.46% | 60 |
|
|
2015
Q4 | $12M | Buy |
39,294
+16,434
| +72% | +$4.72M | 0.55% | 52 |
|
|
2015
Q3 | $6.67M | Buy |
22,860
+9,562
| +72% | +$3.16M | 0.32% | 82 |
|
|
2015
Q2 | $5.37M | Hold |
13,298
| – | – | 0.24% | 113 |
|
|
2015
Q1 | $5.62M | Sell |
13,298
-37
| -0.3% | -$14.6K | 0.26% | 114 |
|
|
2014
Q4 | $4.53M | Hold |
13,335
| – | – | 0.22% | 126 |
|
|
2014
Q3 | $4.41M | Buy |
13,335
+1,094
| +9% | +$361K | 0.21% | 124 |
|
|
2014
Q2 | $3.86M | Hold |
12,241
| – | – | 0.19% | 136 |
|
|
2014
Q1 | $3.74M | Sell |
12,241
-512
| -4% | -$163K | 0.19% | 132 |
|
|
2013
Q4 | $3.57M | Sell |
12,753
-94
| -0.7% | -$24.3K | 0.18% | 131 |
|
|
2013
Q3 | $3.09M | Buy |
12,847
+94
| +0.7% | +$21K | 0.17% | 140 |
|
|
2013
Q2 | $2.75M | Buy |
+12,753
| New | +$2.73M | 0.15% | 140 |
|
Other funds holding BIIB
Whittier Trust's BIIB Position: Q2 2026 in Review
Whittier Trust held its Biogen (BIIB) position steady in Q2 2026 at 699 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #684.
Whittier Trust first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.6M in Q3 2016. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Whittier Trust held 699 shares of Biogen worth $146K as of Q2 2026.
- Whittier Trust left its Biogen share count unchanged in Q2 2026.
- Biogen made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #684 holding.
- Whittier Trust first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- Whittier Trust's Biogen position peaked at $12.6M in Q3 2016.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.